DAVENPORT FRED B JR 4
4 · Medpace Holdings, Inc. · Filed Nov 3, 2025
Insider Transaction Report
Form 4
DAVENPORT FRED B JR
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-10-30−6,472→ 0 totalExercise: $54.99Exp: 2026-05-17→ Common Stock (6,472 underlying) - Exercise/Conversion
Common Stock
2025-10-30$54.99/sh+6,472$355,895→ 9,470 total - Sale
Common Stock
2025-10-30$581.88/sh−5,972$3,474,987→ 3,498 total
Holdings
- 2,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $580.53 to $585.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- [F2]Owned by trust for the benefit of the Reporting Person.
- [F3]The option vested in full on May 14, 2020.